Euclidean Capital LLC Pmv Pharmaceuticals, Inc. Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
A detailed history of Euclidean Capital LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 2,627,643 shares of PMVP stock, worth $4.41 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
2,627,643
Previous 2,627,643
-0.0%
Holding current value
$4.41 Million
Previous $8.15 Million
45.17%
% of portfolio
0.57%
Previous 0.92%
Shares
6 transactions
Others Institutions Holding PMVP
# of Institutions
106Shares Held
45.5MCall Options Held
2KPut Options Held
600-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.9 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.2MShares$5.37 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.11MShares$5.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$4.12 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.94 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $76.6M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...